Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)
Clinical trial NCT02973477 · COMPLETED
Trial details
- NCT number
- NCT02973477
- Sponsor
- University of Michigan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-12
- Primary completion
- 2019-08-22
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.